Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program.


Journal

Human genomics
ISSN: 1479-7364
Titre abrégé: Hum Genomics
Pays: England
ID NLM: 101202210

Informations de publication

Date de publication:
02 06 2023
Historique:
received: 06 09 2022
accepted: 05 05 2023
medline: 5 6 2023
pubmed: 3 6 2023
entrez: 2 6 2023
Statut: epublish

Résumé

The Million Veteran Program (MVP) participants represent 100 years of US history, including significant social and demographic changes over time. Our study assessed two aspects of the MVP: (i) longitudinal changes in population diversity and (ii) how these changes can be accounted for in genome-wide association studies (GWAS). To investigate these aspects, we divided MVP participants into five birth cohorts (N-range = 123,888 [born from 1943 to 1947] to 136,699 [born from 1948 to 1953]). Ancestry groups were defined by (i) HARE (harmonized ancestry and race/ethnicity) and (ii) a random-forest clustering approach using the 1000 Genomes Project and the Human Genome Diversity Project (1kGP + HGDP) reference panels (77 world populations representing six continental groups). In these groups, we performed GWASs of height, a trait potentially affected by population stratification. Birth cohorts demonstrate important trends in ancestry diversity over time. More recent HARE-assigned Europeans, Africans, and Hispanics had lower European ancestry proportions than older birth cohorts (0.010 < Cohen's d < 0.259, p < 7.80 × 10 This study provides a characterization of ancestry diversity of the MVP cohort over time and compares two strategies to infer genetically defined ancestry groups by assessing differences in controlling population stratification in genome-wide association studies.

Sections du résumé

BACKGROUND
The Million Veteran Program (MVP) participants represent 100 years of US history, including significant social and demographic changes over time. Our study assessed two aspects of the MVP: (i) longitudinal changes in population diversity and (ii) how these changes can be accounted for in genome-wide association studies (GWAS). To investigate these aspects, we divided MVP participants into five birth cohorts (N-range = 123,888 [born from 1943 to 1947] to 136,699 [born from 1948 to 1953]).
RESULTS
Ancestry groups were defined by (i) HARE (harmonized ancestry and race/ethnicity) and (ii) a random-forest clustering approach using the 1000 Genomes Project and the Human Genome Diversity Project (1kGP + HGDP) reference panels (77 world populations representing six continental groups). In these groups, we performed GWASs of height, a trait potentially affected by population stratification. Birth cohorts demonstrate important trends in ancestry diversity over time. More recent HARE-assigned Europeans, Africans, and Hispanics had lower European ancestry proportions than older birth cohorts (0.010 < Cohen's d < 0.259, p < 7.80 × 10
CONCLUSIONS
This study provides a characterization of ancestry diversity of the MVP cohort over time and compares two strategies to infer genetically defined ancestry groups by assessing differences in controlling population stratification in genome-wide association studies.

Identifiants

pubmed: 37268996
doi: 10.1186/s40246-023-00487-3
pii: 10.1186/s40246-023-00487-3
pmc: PMC10239111
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA047527
Pays : United States
Organisme : NIDCD NIH HHS
ID : R21 DC018098
Pays : United States
Organisme : NIDA NIH HHS
ID : R33 DA047527
Pays : United States
Organisme : NIMH NIH HHS
ID : F32 MH122058
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Nat Genet. 2021 Dec;53(12):1634-1635
pubmed: 34824479
Science. 2008 Feb 22;319(5866):1100-4
pubmed: 18292342
J Epidemiol. 2017 Mar;27(3S):S2-S8
pubmed: 28189464
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Nat Genet. 2021 Dec;53(12):1631-1633
pubmed: 34824480
PLoS Genet. 2017 May 1;13(5):e1006755
pubmed: 28459806
Int J Epidemiol. 2021 Jul 9;50(3):717-718e
pubmed: 34143882
Commun Biol. 2019 Jan 7;2:9
pubmed: 30623105
N Engl J Med. 2019 Aug 15;381(7):668-676
pubmed: 31412182
Cell. 2019 Oct 17;179(3):589-603
pubmed: 31607513
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Elife. 2019 Mar 21;8:
pubmed: 30895926
Curr Protoc Hum Genet. 2017 Oct 18;95:1.22.1-1.22.23
pubmed: 29044472
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Genet. 2018 May;50(5):737-745
pubmed: 29700474
Am J Hum Genet. 2019 Oct 3;105(4):763-772
pubmed: 31564439
Nat Genet. 2021 Feb;53(2):195-204
pubmed: 33462486
Popul Dev Rev. 2009 Mar;35(1):1-51
pubmed: 20539823
Cell. 2019 Oct 17;179(3):736-749.e15
pubmed: 31626772
Cell. 2019 Mar 21;177(1):26-31
pubmed: 30901543
Genome Res. 2009 Sep;19(9):1655-64
pubmed: 19648217
Am J Hum Genet. 2020 Apr 2;106(4):535-548
pubmed: 32243820
J Clin Epidemiol. 2016 Feb;70:214-23
pubmed: 26441289
Hum Mol Genet. 2021 Jul 9;30(15):1457-1467
pubmed: 33890984

Auteurs

Frank R Wendt (FR)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Gita A Pathak (GA)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Jacqueline Vahey (J)

Durham VA Medical Center, Durham, NC, USA.
Duke University, Carmichael Building, 300 N Duke St, Durham, NC, 27701, USA.

Xuejun Qin (X)

Durham VA Medical Center, Durham, NC, USA.
Duke University, Carmichael Building, 300 N Duke St, Durham, NC, 27701, USA.

Dora Koller (D)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Brenda Cabrera-Mendoza (B)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Angela Haeny (A)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

Kelly M Harrington (KM)

Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.
Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.

Nallakkandi Rajeevan (N)

VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.
Yale Center for Medical Informatics, Yale School of Medicine, New Haven, CT, USA.

Linh M Duong (LM)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Daniel F Levey (DF)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Flavio De Angelis (F)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.

Antonella De Lillo (A)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

Tim B Bigdeli (TB)

SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
VA New York Harbor Healthcare System, Brooklyn, NY, USA.

Saiju Pyarajan (S)

Massachusetts Area Veterans Epidemiology, Research, and Information Center (MAVERIC), Jamaica Plain, MA, USA.
VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard School of Medicine, Boston, MA, USA.

John Michael Gaziano (JM)

VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard School of Medicine, Boston, MA, USA.

Joel Gelernter (J)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Department of Psychiatry, VA CT Healthcare System, West Haven, CT, USA.

Mihaela Aslan (M)

VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Dawn Provenzale (D)

Durham VA Medical Center, Durham, NC, USA.
Duke University, Carmichael Building, 300 N Duke St, Durham, NC, 27701, USA.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Drew A Helmer (DA)

Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Elizabeth R Hauser (ER)

Durham VA Medical Center, Durham, NC, USA. elizabeth.hauser@duke.edu.
Duke University, Carmichael Building, 300 N Duke St, Durham, NC, 27701, USA. elizabeth.hauser@duke.edu.

Renato Polimanti (R)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. renato.polimanti@yale.edu.
VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA CT Healthcare System, VA CT 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA. renato.polimanti@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH